CTLA4 and cancer: Blocking CTLA-4 for immunotherapy of cancer was later steered by James Allison who has played crucial roles in the renaissance of cancer immunology [34–37], whereas Chen’s earlier work laid the groundwork for the therapeutic potential of manipulating co-stimulatory molecules against cancer.